Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Gollins · SciRah

Researcher profile · Semantic Scholar

S. Gollins

Share profile

S. Gollins — researcher profile on SciRah

h-index: 42
Works: 125
Citations: 8,293

Most-cited papers

Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study.
M. V. D. van der Valk, D. Hilling, E. Bastiaannet, Elma Meershoek-Klein Kranenbarg +64 more
2018The Lancet976 citations Open access
Semantic Scholar
Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
A. Renehan, L. Malcomson, R. Emsley, S. Gollins +9 more
2016The Lancet Oncology689 citations
Semantic Scholar
Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial.
R. James, R. Glynne-Jones, H. Meadows, D. Cunningham +13 more
2013The Lancet Oncology652 citations Open access
Semantic Scholar
Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial
D. Agbamu, N. Day, C. Walsh, C. Hendrickse +227 more
2012The Lancet Oncology437 citations Open access
Semantic Scholar
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial.
T. Crosby, C. Hurt, S. Falk, S. Gollins +11 more
2013The Lancet Oncology374 citations Open access
Semantic Scholar
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 Study
J. Valle, H. Wasan, P. Johnson, E. T. Jones +15 more
2009British Journal of Cancer290 citations Open access
Semantic Scholar
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
Richard A. Adams, A. Meade, M. Seymour, Richard H. Wilson +16 more
2011The Lancet Oncology257 citations Open access
Semantic Scholar
Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study.
L. Fernandez, G. P. São Julião, N. Figueiredo, G. Beets +95 more
2020The Lancet Oncology188 citations Open access
Semantic Scholar
Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study
S. Bach, A. Gilbert, K. Brock, S. Korsgen +149 more
2020The Lancet Gastroenterology and Hepatology172 citations Open access
Semantic Scholar
Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis.
S. Chadi, L. Malcomson, J. Ensor, R. Riley +29 more
2018The Lancet Gastroenterology and Hepatology168 citations Open access
Semantic Scholar
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial
T. Iveson, R. Kerr, M. Saunders, J. Cassidy +32 more
2018The Lancet Oncology165 citations Open access
Semantic Scholar
Evaluation of pre-analytical factors affecting plasma DNA analysis
Havell Markus, T. Contente-Cuomo, M. Farooq, W. Liang +12 more
2017Scientific Reports149 citations Open access
Semantic Scholar
EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer.
R. Glynne-Jones, H. Meadows, S. Wan, S. Gollins +6 more
2008International Journal of Radiation Oncology, Biology, Physics143 citations
Semantic Scholar
Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) – Multidisciplinary Management
S. Gollins, B. Moran, R. Adams, C. Cunningham +9 more
2017Colorectal Disease101 citations Open access
Semantic Scholar
Prognostic factors for recurrence and survival in anal cancer
R. Glynne-Jones, D. Sebag-Montefiore, R. Adams, S. Gollins +3 more
2013Cancer97 citations
Semantic Scholar
Common, important, and unmet needs of cancer outpatients.
Val Morrison, B. J. Henderson, F. Zinovieff, G. Davies +3 more
2012European Journal of Oncology Nursing80 citations
Semantic Scholar
Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer.
S. Gollins, D. Sebag-Montefiore
2016Clinics in oncology79 citations Open access
Semantic Scholar
Dose Escalation Using Contact X-ray Brachytherapy After External Beam Radiotherapy as Nonsurgical Treatment Option for Rectal Cancer: Outcomes From a Single-Center Experience.
Arthur Sun Myint, F. Smith, S. Gollins, H. Wong +6 more
2017International Journal of Radiation Oncology, Biology, Physics74 citations
Semantic Scholar
Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer
T. Crosby, C. Hurt, S. Falk, S. Gollins +10 more
2017British Journal of Cancer71 citations Open access
Semantic Scholar
Clinical and cellular roles for TDP1 and TOP1 in modulating colorectal cancer response to irinotecan
C. Meisenberg, D. Gilbert, A. Chalmers, V. Haley +3 more
2014Molecular Cancer Therapeutics69 citations Open access
Semantic Scholar
Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD)
S. Temmink, K. Peeters, R. Bahadoer, E. Kranenbarg +71 more
2023British Journal of Surgery66 citations Open access
Semantic Scholar
Prospective patient stratification into robust cancer‐cell intrinsic subtypes from colorectal cancer biopsies
M. Alderdice, S. Richman, S. Gollins, J. Stewart +11 more
2018Journal of Pathology66 citations Open access
Semantic Scholar
How do clinicians rate patient’s performance status using the ECOG performance scale? A mixed-methods exploration of variability in decision-making in oncology
S. Datta, N. Ghosal, Rhea Daruvala, Santam Chakraborty +8 more
2019ecancermedicalscience63 citations Open access
Semantic Scholar
"Mind the gap"--the impact of variations in the duration of the treatment gap and overall treatment time in the first UK Anal Cancer Trial (ACT I).
R. Glynne-Jones, D. Sebag-Montefiore, R. Adams, A. Mcdonald +5 more
2011International Journal of Radiation Oncology, Biology, Physics58 citations
Semantic Scholar
Preoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: impact on long-term clinical outcomes.
S. Gollins, Arthur Sun Myint, B. Haylock, M. Wise +9 more
2011Journal of Clinical Oncology55 citations
Semantic Scholar
SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus
C. Hurt, L. Nixon, G. Griffiths, Ruby Al-Mokhtar +5 more
2011BMC Cancer54 citations Open access
Semantic Scholar
Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) – Anal Cancer
I. Geh, S. Gollins, A. Renehan, J. Scholefield +6 more
2017Colorectal Disease50 citations Open access
Semantic Scholar
Circulating Tumor Cell Enumeration in a Phase II Trial of a Four-Drug Regimen in Advanced Colorectal Cancer.
M. Krebs, A. Renehan, A. Backen, S. Gollins +8 more
2015Clinical colorectal cancer50 citations
Semantic Scholar
Dose escalation using contact X-ray brachytherapy (Papillon) for rectal cancer: does it improve the chance of organ preservation?
Arthur Sun Myint, F. Smith, S. Gollins, H. Wong +8 more
2017British Journal of Radiology49 citations Open access
Semantic Scholar
Brachyury identifies a class of enteroendocrine cells in normal human intestinal crypts and colorectal cancer
J. Ježková, Jason S. Williams, F. Pinto, S. Sammut +5 more
2016OncoTarget47 citations Open access
Semantic Scholar
NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
S. Mukherjee, C. Hurt, S. Gwynne, D. Sebag-Montefiore +14 more
2017European Journal of Cancer43 citations Open access
Semantic Scholar
Primary squamous cell carcinoma of the pancreas: a case report and review of the literature
R. Kodavatiganti, Fiona Campbell, A. Hashmi, S. Gollins
2012Journal of Medical Case Reports40 citations Open access
Semantic Scholar
Patient-reported measurement of time to diagnosis in cancer: development of the Cancer Symptom Interval Measure (C-SIM) and randomised controlled trial of method of delivery
R. Neal, S. Nafees, D. Pasterfield, K. Hood +9 more
2014BMC Health Services Research38 citations Open access
Semantic Scholar
Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer
J. Rees, C. Hurt, S. Gollins, S. Mukherjee +13 more
2015British Journal of Cancer36 citations Open access
Semantic Scholar
NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma
S. Mukherjee, C. Hurt, S. Gwynne, A. Bateman +15 more
2015BMC Cancer35 citations Open access
Semantic Scholar
Systematic review of treatment intensification using novel agents for chemoradiotherapy in rectal cancer
R. Clifford, N. Govindarajah, J. Parsons, S. Gollins +2 more
2018British Journal of Surgery32 citations Open access
Semantic Scholar
A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS
S. Gollins, N. West, D. Sebag-Montefiore, S. Susnerwala +10 more
2018British Journal of Cancer32 citations Open access
Semantic Scholar
Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy
Maxime W. Lafarge, Enric Domingo, K. Sirinukunwattana, Ruby Wood +16 more
2023npj Precision Oncology31 citations Open access
Semantic Scholar
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
T. Iveson, K. Boyd, R. Kerr, J. Robles-Zurita +33 more
2019Health Technology Assessment30 citations Open access
Semantic Scholar
Oesophageal Chemoradiotherapy in the UK--current practice and future directions.
S. Gwynne, S. Falk, S. Gollins, L. Wills +11 more
2013Clinics in oncology29 citations
Semantic Scholar
A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO).
G. Middleton, Sarah R. Brown, C. Lowe, T. Maughan +16 more
2013European Journal of Cancer29 citations
Semantic Scholar
Intensity-modulated Radiotherapy for Rectal Cancer in the UK in 2020
C. Hanna, F. Slevin, A. Appelt, M. Beavon +16 more
2021Clinics in oncology28 citations Open access
Semantic Scholar
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations
S. Gollins, N. West, D. Sebag-Montefiore, A. Myint +16 more
2017British Journal of Cancer28 citations Open access
Semantic Scholar
Preoperative neo‐adjuvant therapy for curable rectal cancer – reaching a consensus 2008
N. Scott, S. Susnerwala, S. Gollins, A. Myint +1 more
2009Colorectal Disease27 citations Open access
Semantic Scholar
Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004)
C. Nutting, J. Morden, M. Beasley, S. Bhide +25 more
2018European Journal of Cancer26 citations Open access
Semantic Scholar
Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2)
S. Gollins, S. Myint, S. Susnerwala, B. Haylock +7 more
2009British Journal of Cancer24 citations Open access
Semantic Scholar
SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer
J. Robles-Zurita, K. Boyd, A. Briggs, T. Iveson +33 more
2018British Journal of Cancer22 citations Open access
Semantic Scholar
Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study
T. Waddell, S. Gollins, W. Soe, Juan W. Valle +7 more
2011Cancer Chemotherapy and Pharmacology22 citations Open access
Semantic Scholar
ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).
D. Sebag-Montefiore, R. Adams, S. Gollins, L. Samuel +16 more
2020Journal of Clinical Oncology18 citations
Semantic Scholar
Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy: Post Hoc Analysis of the SCOT Randomized Clinical Trial.
M. Gögenur, Andreas Weinberger Rosen, T. Iveson, R. Kerr +28 more
2024JAMA Surgery17 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Sebag-Montefiore×12
Invite
D. Sebag-Montefiore — researcher profile on SciRah
M. Saunders×11
Invite
M. Saunders — researcher profile on SciRah
S. Falk×11
Invite
S. Falk — researcher profile on SciRah
T. Maughan×10
Invite
T. Maughan — researcher profile on SciRah

×8

Invite

A. Renehan — researcher profile on SciRah

S. Susnerwala×8

Invite

S. Susnerwala — researcher profile on SciRah

Invite

C. Hurt — researcher profile on SciRah

J. Bridgewater×8

Invite

J. Bridgewater — researcher profile on SciRah

Invite

A. Myint — researcher profile on SciRah

Invite

S. Essapen — researcher profile on SciRah

Invite

T. Crosby — researcher profile on SciRah

D. Cunningham×6

Invite

D. Cunningham — researcher profile on SciRah